Singapore, 2025: Expecto Health Science, a fast-growing Contract Research Organization (CRO) headquartered in Singapore, is pleased to announce the appointment of Dr. Samir Sadekar as Vice President, Clinical Operations. This strategic hire supports Expecto’s ambitious growth plans to become a leading APAC-focused CRO known for scientific excellence, regional expertise, and globally trusted clinical trial delivery.
With over two decades of experience in clinical research and drug development, Dr. Sadekar brings deep expertise in clinical operations, regulatory strategy, and cross-functional team leadership across international markets. He has held senior roles at multinational pharmaceutical companies and global CROs, leading successful clinical programs across therapeutic areas such as oncology, immunology, and rare diseases.
Dr. Sadekar is widely recognised in the industry for his visionary leadership, operational rigour, and commitment to advancing patient centric research. His addition to the leadership team at Expecto will further strengthen the company’s capability to deliver high-quality, efficient, and compliant clinical trials across Asia-Pacific and beyond.
“We are thrilled to welcome Dr. Samir Sadekar to Expecto,” said Dr. Pramod Kashid, CEO of Expecto Health Science. “His wealth of experience and leadership style aligns perfectly with our mission to transform clinical research delivery in the APAC region. This is a pivotal step in scaling our operational capabilities and serving our global clients with excellence.”
As Vice President of Clinical Operations, Dr. Sadekar will oversee clinical delivery teams, drive operational strategy, and play a key role in expanding Expecto’s presence across emerging APAC markets. His leadership will support Expecto’s ongoing efforts to uphold scientific integrity, regulatory compliance, and promote patient diversity in clinical development.
To learn more about Dr. Sadekar’s background, visit his LinkedIn profile
About Expecto Health Science
Expecto Health Science is an emerging full-service Contract Research Organization (CRO) headquartered in Singapore, with operations across Asia-Pacific. Expecto is dedicated to advancing clinical development through innovative, efficient, and inclusive trial delivery. Company is advocating its mission to make clinical research more accessible, efficient, and locally relevant, while upholding global quality standards. With expertise spanning oncology, infectious diseases, medical devices, and dermatology, Expecto partners with biotech, pharma, and academic organisations to bring life-changing therapies to patients across the region.
Media Contact:
Simon Wong
Chief Business Officer
Expecto Health Science
Web: www.expectohealth.com
Disclaimer –
This article is a work of original content created for public relations and informational purposes only. It may be published across multiple digital platforms with the full knowledge and consent of the author/publisher. All images, logos, and referenced names are the property of their respective owners and used here solely for illustrative or informational purposes. Unauthorized reproduction, distribution, or modification of this article without prior written permission from the original publisher is strictly prohibited. Any resemblance to other content is purely coincidental or used under fair use policy with proper attribution.
Read More : The Most Prominent Business Leaders To Follow in Artificial Intelligence
